Michael Bruce
Chief Executive Officer bij Exo Therapeutics, Inc.
Profiel
Michael Bruce is currently the Chief Executive Officer at Exo Therapeutics, Inc. Prior to this, he was the Senior Vice President of Development Operations at Kaleido Biosciences, Inc. from 2018 to 2020.
He was also the Senior VP of Program Portfolio & Alliance Management at CRISPR Therapeutics AG from 2015 to 2017.
Before that, he held the position of Vice President of Development Operations at Wyeth LLC from 2003 to 2015 and Vice President at Pfizer Inc. from 2003 to 2015.
Dr. Bruce holds a doctorate degree from Stanford University and an undergraduate degree from Williams College.
Actieve functies van Michael Bruce
| Bedrijven | Functie | Begin |
|---|---|---|
Exo Therapeutics, Inc.
 Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Chief Executive Officer | 01-02-2020 |
Eerdere bekende functies van Michael Bruce
| Bedrijven | Functie | Einde |
|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Corporate Officer/Principal | 01-02-2020 |
| CRISPR THERAPEUTICS AG | Corporate Officer/Principal | 01-01-2017 |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | 01-01-2015 |
| PFIZER, INC. | Corporate Officer/Principal | 01-01-2015 |
Opleiding van Michael Bruce
| Stanford University | Doctorate Degree |
| Williams College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| CRISPR THERAPEUTICS AG | Health Technology |
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Health Technology |
